Global Drug Delivery Devices Market

Drug Delivery Devices Comprehensive Study by Type (Ambulatory infusion pumps, Valves, Needles, Paediatric IV set, Others), Application (Pharmaceutical companies, Hospitals, Clinics, Others), Delivery route (Oral route, Parenteral route, Transdermal route, Inhalation route), Route of administration (Oral Drug Delivery, Pulmonary Drug Delivery, Inject able Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Tran mucosal Drug Delivery), End User (Hospitals,, Ambulatory Surgical Centers,, Home Care settings,, Diagnostic Centers,, Other) Players and Region - Global Market Outlook to 2026

Drug Delivery Devices Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Drug delivery devices refer as tools which are made for the delivery of a drug or therapeutic agent via the specific route of administration. Such devices are used as a part of one or more medical treatments. These devices help in increasing the efficiency of drug delivery system by controlling dosage, time, and place of release of the drugs in the body. The market of the Drug Delivery Devices is increasing due to the rising accessibility and affordability of the drug delivery devices, whereas strict regulatory requirements for approval of drug delivery devices may hinder the market growthAccording to AMA, the market for Drug Delivery Devices is expected to register a CAGR of 7.8% during the forecast period to 2026. This growth is primarily driven by Increasing demand for improved drug delivery systems, Rising accessibility and affordability of drug delivery devices and Increasing number of chronic diseases in the region.

Globally, a noticeable market trend is evident Innovations such as infusion pens creating opportunities for new players . The Medical Devices sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Antares Pharma Inc. (United States), Becton, Dickinson and Company (United States), Bayer AG (Germany), Glaxsmithkline PLC (United Kingdom), Johnson & Johnson Services Inc. (United States), Merck & Co., Inc. (United States), Novartis AG (Switzerland), Pfizer Inc. (United States) and Sanofi. (France) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:

Antares pharma announces the commercial availability of xyosted (testosterone enanthate) injection, which is a new treatment for adult men diagnosed with testosterone deficiency

Market Drivers
  • Increasing demand for improved drug delivery systems
  • Rising accessibility and affordability of drug delivery devices
  • Increasing number of chronic diseases in the region

Market Trend
  • Innovations such as infusion pens creating opportunities for new players
  • Healthcare at home
  • Collaborations and partnerships among companies in the market

Restraints
  • Safety, quality and consistent performance
  • Lack of skilled and trained professionals to administer drugs

Opportunities
Improving economic conditions in the region and Rising geriatric population, technological advancements, and increasing demand for improved drug delivery systems
Challenges
Strict regulatory requirements for approval of drug delivery devices and Problems related to the use of drug delivery devices such as dosage error

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Drug Delivery Devices Study Sheds Light on
— The Drug Delivery Devices Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Drug Delivery Devices industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Drug Delivery Devices industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Ambulatory infusion pumps
  • Valves
  • Needles
  • Paediatric IV set
  • Others
By Application
  • Pharmaceutical companies
  • Hospitals
  • Clinics
  • Others
By Delivery route
  • Oral route
  • Parenteral route
  • Transdermal route
  • Inhalation route

By Route of administration
  • Oral Drug Delivery
  • Pulmonary Drug Delivery
  • Inject able Drug Delivery
  • Ocular Drug Delivery
  • Nasal Drug Delivery
  • Topical Drug Delivery
  • Implantable Drug Delivery
  • Tran mucosal Drug Delivery

By End User
  • Hospitals,
  • Ambulatory Surgical Centers,
  • Home Care settings,
  • Diagnostic Centers,
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing demand for improved drug delivery systems
      • 3.2.2. Rising accessibility and affordability of drug delivery devices
      • 3.2.3. Increasing number of chronic diseases in the region
    • 3.3. Market Challenges
      • 3.3.1. Strict regulatory requirements for approval of drug delivery devices
      • 3.3.2. Problems related to the use of drug delivery devices such as dosage error
    • 3.4. Market Trends
      • 3.4.1. Innovations such as infusion pens creating opportunities for new players
      • 3.4.2. Healthcare at home
      • 3.4.3. Collaborations and partnerships among companies in the market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Delivery Devices, by Type, Application, Delivery route, Route of administration, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Drug Delivery Devices (Value)
      • 5.2.1. Global Drug Delivery Devices by: Type (Value)
        • 5.2.1.1. Ambulatory infusion pumps
        • 5.2.1.2. Valves
        • 5.2.1.3. Needles
        • 5.2.1.4. Paediatric IV set
        • 5.2.1.5. Others
      • 5.2.2. Global Drug Delivery Devices by: Application (Value)
        • 5.2.2.1. Pharmaceutical companies
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Clinics
        • 5.2.2.4. Others
      • 5.2.3. Global Drug Delivery Devices by: Delivery route (Value)
        • 5.2.3.1. Oral route
        • 5.2.3.2. Parenteral route
        • 5.2.3.3. Transdermal route
        • 5.2.3.4. Inhalation route
      • 5.2.4. Global Drug Delivery Devices by: Route of administration (Value)
        • 5.2.4.1. Oral Drug Delivery
        • 5.2.4.2. Pulmonary Drug Delivery
        • 5.2.4.3. Inject able Drug Delivery
        • 5.2.4.4. Ocular Drug Delivery
        • 5.2.4.5. Nasal Drug Delivery
        • 5.2.4.6. Topical Drug Delivery
        • 5.2.4.7. Implantable Drug Delivery
        • 5.2.4.8. Tran mucosal Drug Delivery
      • 5.2.5. Global Drug Delivery Devices by: End User (Value)
        • 5.2.5.1. Hospitals,
        • 5.2.5.2. Ambulatory Surgical Centers,
        • 5.2.5.3. Home Care settings,
        • 5.2.5.4. Diagnostic Centers,
        • 5.2.5.5. Other
      • 5.2.6. Global Drug Delivery Devices Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Drug Delivery Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Antares Pharma Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Glaxsmithkline PLC (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson & Johnson Services Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck & Co., Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pfizer Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sanofi. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Drug Delivery Devices Sale, by Type, Application, Delivery route, Route of administration, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Drug Delivery Devices (Value)
      • 7.2.1. Global Drug Delivery Devices by: Type (Value)
        • 7.2.1.1. Ambulatory infusion pumps
        • 7.2.1.2. Valves
        • 7.2.1.3. Needles
        • 7.2.1.4. Paediatric IV set
        • 7.2.1.5. Others
      • 7.2.2. Global Drug Delivery Devices by: Application (Value)
        • 7.2.2.1. Pharmaceutical companies
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Clinics
        • 7.2.2.4. Others
      • 7.2.3. Global Drug Delivery Devices by: Delivery route (Value)
        • 7.2.3.1. Oral route
        • 7.2.3.2. Parenteral route
        • 7.2.3.3. Transdermal route
        • 7.2.3.4. Inhalation route
      • 7.2.4. Global Drug Delivery Devices by: Route of administration (Value)
        • 7.2.4.1. Oral Drug Delivery
        • 7.2.4.2. Pulmonary Drug Delivery
        • 7.2.4.3. Inject able Drug Delivery
        • 7.2.4.4. Ocular Drug Delivery
        • 7.2.4.5. Nasal Drug Delivery
        • 7.2.4.6. Topical Drug Delivery
        • 7.2.4.7. Implantable Drug Delivery
        • 7.2.4.8. Tran mucosal Drug Delivery
      • 7.2.5. Global Drug Delivery Devices by: End User (Value)
        • 7.2.5.1. Hospitals,
        • 7.2.5.2. Ambulatory Surgical Centers,
        • 7.2.5.3. Home Care settings,
        • 7.2.5.4. Diagnostic Centers,
        • 7.2.5.5. Other
      • 7.2.6. Global Drug Delivery Devices Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Delivery Devices: by Type(USD Billion)
  • Table 2. Drug Delivery Devices Ambulatory infusion pumps , by Region USD Billion (2015-2020)
  • Table 3. Drug Delivery Devices Valves , by Region USD Billion (2015-2020)
  • Table 4. Drug Delivery Devices Needles , by Region USD Billion (2015-2020)
  • Table 5. Drug Delivery Devices Paediatric IV set , by Region USD Billion (2015-2020)
  • Table 6. Drug Delivery Devices Others , by Region USD Billion (2015-2020)
  • Table 7. Drug Delivery Devices: by Application(USD Billion)
  • Table 8. Drug Delivery Devices Pharmaceutical companies , by Region USD Billion (2015-2020)
  • Table 9. Drug Delivery Devices Hospitals , by Region USD Billion (2015-2020)
  • Table 10. Drug Delivery Devices Clinics , by Region USD Billion (2015-2020)
  • Table 11. Drug Delivery Devices Others , by Region USD Billion (2015-2020)
  • Table 12. Drug Delivery Devices: by Delivery route(USD Billion)
  • Table 13. Drug Delivery Devices Oral route , by Region USD Billion (2015-2020)
  • Table 14. Drug Delivery Devices Parenteral route , by Region USD Billion (2015-2020)
  • Table 15. Drug Delivery Devices Transdermal route , by Region USD Billion (2015-2020)
  • Table 16. Drug Delivery Devices Inhalation route , by Region USD Billion (2015-2020)
  • Table 17. Drug Delivery Devices: by Route of administration(USD Billion)
  • Table 18. Drug Delivery Devices Oral Drug Delivery , by Region USD Billion (2015-2020)
  • Table 19. Drug Delivery Devices Pulmonary Drug Delivery , by Region USD Billion (2015-2020)
  • Table 20. Drug Delivery Devices Inject able Drug Delivery , by Region USD Billion (2015-2020)
  • Table 21. Drug Delivery Devices Ocular Drug Delivery , by Region USD Billion (2015-2020)
  • Table 22. Drug Delivery Devices Nasal Drug Delivery , by Region USD Billion (2015-2020)
  • Table 23. Drug Delivery Devices Topical Drug Delivery , by Region USD Billion (2015-2020)
  • Table 24. Drug Delivery Devices Implantable Drug Delivery , by Region USD Billion (2015-2020)
  • Table 25. Drug Delivery Devices Tran mucosal Drug Delivery , by Region USD Billion (2015-2020)
  • Table 26. Drug Delivery Devices: by End User(USD Billion)
  • Table 27. Drug Delivery Devices Hospitals, , by Region USD Billion (2015-2020)
  • Table 28. Drug Delivery Devices Ambulatory Surgical Centers, , by Region USD Billion (2015-2020)
  • Table 29. Drug Delivery Devices Home Care settings, , by Region USD Billion (2015-2020)
  • Table 30. Drug Delivery Devices Diagnostic Centers, , by Region USD Billion (2015-2020)
  • Table 31. Drug Delivery Devices Other , by Region USD Billion (2015-2020)
  • Table 32. South America Drug Delivery Devices, by Country USD Billion (2015-2020)
  • Table 33. South America Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 34. South America Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 35. South America Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 36. South America Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 37. South America Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 38. Brazil Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 39. Brazil Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 40. Brazil Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 41. Brazil Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 42. Brazil Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 43. Argentina Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 44. Argentina Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 45. Argentina Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 46. Argentina Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 47. Argentina Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 48. Rest of South America Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 49. Rest of South America Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 50. Rest of South America Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 51. Rest of South America Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 52. Rest of South America Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 53. Asia Pacific Drug Delivery Devices, by Country USD Billion (2015-2020)
  • Table 54. Asia Pacific Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 55. Asia Pacific Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 56. Asia Pacific Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 57. Asia Pacific Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 58. Asia Pacific Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 59. China Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 60. China Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 61. China Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 62. China Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 63. China Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 64. Japan Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 65. Japan Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 66. Japan Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 67. Japan Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 68. Japan Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 69. India Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 70. India Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 71. India Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 72. India Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 73. India Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 74. South Korea Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 75. South Korea Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 76. South Korea Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 77. South Korea Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 78. South Korea Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 79. Taiwan Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 80. Taiwan Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 81. Taiwan Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 82. Taiwan Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 83. Taiwan Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 84. Australia Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 85. Australia Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 86. Australia Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 87. Australia Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 88. Australia Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 89. Rest of Asia-Pacific Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 90. Rest of Asia-Pacific Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 91. Rest of Asia-Pacific Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 92. Rest of Asia-Pacific Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 93. Rest of Asia-Pacific Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 94. Europe Drug Delivery Devices, by Country USD Billion (2015-2020)
  • Table 95. Europe Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 96. Europe Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 97. Europe Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 98. Europe Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 99. Europe Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 100. Germany Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 101. Germany Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 102. Germany Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 103. Germany Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 104. Germany Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 105. France Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 106. France Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 107. France Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 108. France Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 109. France Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 110. Italy Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 111. Italy Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 112. Italy Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 113. Italy Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 114. Italy Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 115. United Kingdom Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 116. United Kingdom Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 117. United Kingdom Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 118. United Kingdom Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 119. United Kingdom Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 120. Netherlands Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 121. Netherlands Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 122. Netherlands Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 123. Netherlands Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 124. Netherlands Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 125. Rest of Europe Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 126. Rest of Europe Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 127. Rest of Europe Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 128. Rest of Europe Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 129. Rest of Europe Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 130. MEA Drug Delivery Devices, by Country USD Billion (2015-2020)
  • Table 131. MEA Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 132. MEA Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 133. MEA Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 134. MEA Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 135. MEA Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 136. Middle East Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 137. Middle East Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 138. Middle East Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 139. Middle East Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 140. Middle East Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 141. Africa Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 142. Africa Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 143. Africa Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 144. Africa Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 145. Africa Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 146. North America Drug Delivery Devices, by Country USD Billion (2015-2020)
  • Table 147. North America Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 148. North America Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 149. North America Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 150. North America Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 151. North America Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 152. United States Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 153. United States Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 154. United States Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 155. United States Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 156. United States Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 157. Canada Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 158. Canada Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 159. Canada Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 160. Canada Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 161. Canada Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 162. Mexico Drug Delivery Devices, by Type USD Billion (2015-2020)
  • Table 163. Mexico Drug Delivery Devices, by Application USD Billion (2015-2020)
  • Table 164. Mexico Drug Delivery Devices, by Delivery route USD Billion (2015-2020)
  • Table 165. Mexico Drug Delivery Devices, by Route of administration USD Billion (2015-2020)
  • Table 166. Mexico Drug Delivery Devices, by End User USD Billion (2015-2020)
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Company Basic Information, Sales Area and Its Competitors
  • Table 176. Drug Delivery Devices: by Type(USD Billion)
  • Table 177. Drug Delivery Devices Ambulatory infusion pumps , by Region USD Billion (2021-2026)
  • Table 178. Drug Delivery Devices Valves , by Region USD Billion (2021-2026)
  • Table 179. Drug Delivery Devices Needles , by Region USD Billion (2021-2026)
  • Table 180. Drug Delivery Devices Paediatric IV set , by Region USD Billion (2021-2026)
  • Table 181. Drug Delivery Devices Others , by Region USD Billion (2021-2026)
  • Table 182. Drug Delivery Devices: by Application(USD Billion)
  • Table 183. Drug Delivery Devices Pharmaceutical companies , by Region USD Billion (2021-2026)
  • Table 184. Drug Delivery Devices Hospitals , by Region USD Billion (2021-2026)
  • Table 185. Drug Delivery Devices Clinics , by Region USD Billion (2021-2026)
  • Table 186. Drug Delivery Devices Others , by Region USD Billion (2021-2026)
  • Table 187. Drug Delivery Devices: by Delivery route(USD Billion)
  • Table 188. Drug Delivery Devices Oral route , by Region USD Billion (2021-2026)
  • Table 189. Drug Delivery Devices Parenteral route , by Region USD Billion (2021-2026)
  • Table 190. Drug Delivery Devices Transdermal route , by Region USD Billion (2021-2026)
  • Table 191. Drug Delivery Devices Inhalation route , by Region USD Billion (2021-2026)
  • Table 192. Drug Delivery Devices: by Route of administration(USD Billion)
  • Table 193. Drug Delivery Devices Oral Drug Delivery , by Region USD Billion (2021-2026)
  • Table 194. Drug Delivery Devices Pulmonary Drug Delivery , by Region USD Billion (2021-2026)
  • Table 195. Drug Delivery Devices Inject able Drug Delivery , by Region USD Billion (2021-2026)
  • Table 196. Drug Delivery Devices Ocular Drug Delivery , by Region USD Billion (2021-2026)
  • Table 197. Drug Delivery Devices Nasal Drug Delivery , by Region USD Billion (2021-2026)
  • Table 198. Drug Delivery Devices Topical Drug Delivery , by Region USD Billion (2021-2026)
  • Table 199. Drug Delivery Devices Implantable Drug Delivery , by Region USD Billion (2021-2026)
  • Table 200. Drug Delivery Devices Tran mucosal Drug Delivery , by Region USD Billion (2021-2026)
  • Table 201. Drug Delivery Devices: by End User(USD Billion)
  • Table 202. Drug Delivery Devices Hospitals, , by Region USD Billion (2021-2026)
  • Table 203. Drug Delivery Devices Ambulatory Surgical Centers, , by Region USD Billion (2021-2026)
  • Table 204. Drug Delivery Devices Home Care settings, , by Region USD Billion (2021-2026)
  • Table 205. Drug Delivery Devices Diagnostic Centers, , by Region USD Billion (2021-2026)
  • Table 206. Drug Delivery Devices Other , by Region USD Billion (2021-2026)
  • Table 207. South America Drug Delivery Devices, by Country USD Billion (2021-2026)
  • Table 208. South America Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 209. South America Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 210. South America Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 211. South America Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 212. South America Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 213. Brazil Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 214. Brazil Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 215. Brazil Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 216. Brazil Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 217. Brazil Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 218. Argentina Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 219. Argentina Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 220. Argentina Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 221. Argentina Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 222. Argentina Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 223. Rest of South America Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 224. Rest of South America Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 225. Rest of South America Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 226. Rest of South America Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 227. Rest of South America Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 228. Asia Pacific Drug Delivery Devices, by Country USD Billion (2021-2026)
  • Table 229. Asia Pacific Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 230. Asia Pacific Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 231. Asia Pacific Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 232. Asia Pacific Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 233. Asia Pacific Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 234. China Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 235. China Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 236. China Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 237. China Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 238. China Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 239. Japan Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 240. Japan Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 241. Japan Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 242. Japan Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 243. Japan Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 244. India Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 245. India Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 246. India Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 247. India Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 248. India Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 249. South Korea Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 250. South Korea Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 251. South Korea Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 252. South Korea Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 253. South Korea Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 254. Taiwan Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 255. Taiwan Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 256. Taiwan Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 257. Taiwan Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 258. Taiwan Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 259. Australia Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 260. Australia Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 261. Australia Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 262. Australia Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 263. Australia Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 264. Rest of Asia-Pacific Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 265. Rest of Asia-Pacific Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 266. Rest of Asia-Pacific Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 267. Rest of Asia-Pacific Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 268. Rest of Asia-Pacific Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 269. Europe Drug Delivery Devices, by Country USD Billion (2021-2026)
  • Table 270. Europe Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 271. Europe Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 272. Europe Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 273. Europe Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 274. Europe Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 275. Germany Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 276. Germany Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 277. Germany Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 278. Germany Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 279. Germany Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 280. France Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 281. France Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 282. France Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 283. France Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 284. France Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 285. Italy Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 286. Italy Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 287. Italy Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 288. Italy Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 289. Italy Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 290. United Kingdom Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 291. United Kingdom Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 292. United Kingdom Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 293. United Kingdom Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 294. United Kingdom Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 295. Netherlands Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 296. Netherlands Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 297. Netherlands Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 298. Netherlands Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 299. Netherlands Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 300. Rest of Europe Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 301. Rest of Europe Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 302. Rest of Europe Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 303. Rest of Europe Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 304. Rest of Europe Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 305. MEA Drug Delivery Devices, by Country USD Billion (2021-2026)
  • Table 306. MEA Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 307. MEA Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 308. MEA Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 309. MEA Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 310. MEA Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 311. Middle East Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 312. Middle East Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 313. Middle East Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 314. Middle East Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 315. Middle East Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 316. Africa Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 317. Africa Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 318. Africa Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 319. Africa Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 320. Africa Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 321. North America Drug Delivery Devices, by Country USD Billion (2021-2026)
  • Table 322. North America Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 323. North America Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 324. North America Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 325. North America Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 326. North America Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 327. United States Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 328. United States Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 329. United States Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 330. United States Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 331. United States Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 332. Canada Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 333. Canada Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 334. Canada Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 335. Canada Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 336. Canada Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 337. Mexico Drug Delivery Devices, by Type USD Billion (2021-2026)
  • Table 338. Mexico Drug Delivery Devices, by Application USD Billion (2021-2026)
  • Table 339. Mexico Drug Delivery Devices, by Delivery route USD Billion (2021-2026)
  • Table 340. Mexico Drug Delivery Devices, by Route of administration USD Billion (2021-2026)
  • Table 341. Mexico Drug Delivery Devices, by End User USD Billion (2021-2026)
  • Table 342. Research Programs/Design for This Report
  • Table 343. Key Data Information from Secondary Sources
  • Table 344. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Delivery Devices: by Type USD Billion (2015-2020)
  • Figure 5. Global Drug Delivery Devices: by Application USD Billion (2015-2020)
  • Figure 6. Global Drug Delivery Devices: by Delivery route USD Billion (2015-2020)
  • Figure 7. Global Drug Delivery Devices: by Route of administration USD Billion (2015-2020)
  • Figure 8. Global Drug Delivery Devices: by End User USD Billion (2015-2020)
  • Figure 9. South America Drug Delivery Devices Share (%), by Country
  • Figure 10. Asia Pacific Drug Delivery Devices Share (%), by Country
  • Figure 11. Europe Drug Delivery Devices Share (%), by Country
  • Figure 12. MEA Drug Delivery Devices Share (%), by Country
  • Figure 13. North America Drug Delivery Devices Share (%), by Country
  • Figure 14. Global Drug Delivery Devices share by Players 2020 (%)
  • Figure 15. Global Drug Delivery Devices share by Players (Top 3) 2020(%)
  • Figure 16. Global Drug Delivery Devices share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Antares Pharma Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Antares Pharma Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 21. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 22. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 24. Glaxsmithkline PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Glaxsmithkline PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 26. Johnson & Johnson Services Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Johnson & Johnson Services Inc. (United States) Revenue: by Geography 2020
  • Figure 28. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 32. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Sanofi. (France) Revenue, Net Income and Gross profit
  • Figure 35. Sanofi. (France) Revenue: by Geography 2020
  • Figure 36. Global Drug Delivery Devices: by Type USD Billion (2021-2026)
  • Figure 37. Global Drug Delivery Devices: by Application USD Billion (2021-2026)
  • Figure 38. Global Drug Delivery Devices: by Delivery route USD Billion (2021-2026)
  • Figure 39. Global Drug Delivery Devices: by Route of administration USD Billion (2021-2026)
  • Figure 40. Global Drug Delivery Devices: by End User USD Billion (2021-2026)
  • Figure 41. South America Drug Delivery Devices Share (%), by Country
  • Figure 42. Asia Pacific Drug Delivery Devices Share (%), by Country
  • Figure 43. Europe Drug Delivery Devices Share (%), by Country
  • Figure 44. MEA Drug Delivery Devices Share (%), by Country
  • Figure 45. North America Drug Delivery Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Antares Pharma Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Bayer AG (Germany)
  • Glaxsmithkline PLC (United Kingdom)
  • Johnson & Johnson Services Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (United States)
  • Sanofi. (France)
Additional players considered in the study are as follows:
Bend Research (United States) , Endocyte (United States) , MicroCHIPS Inc (United States) , Pearl Therapeutics Inc (United States) , Presage Bioscience (United States) , Genentech Inc (United States)
Select User Access Type

Key Highlights of Report


Jul 2021 224 Pages 52 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Delivery Devices Market Quantitative research analysis
Global Drug Delivery Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Drug Delivery Devices market is expected to see a CAGR of 7.8% during projected year 2020 to 2026.
Top performing companies in the Global Drug Delivery Devices market are Antares Pharma Inc. (United States), Becton, Dickinson and Company (United States), Bayer AG (Germany), Glaxsmithkline PLC (United Kingdom), Johnson & Johnson Services Inc. (United States), Merck & Co., Inc. (United States), Novartis AG (Switzerland), Pfizer Inc. (United States) and Sanofi. (France), to name a few.
North America is dominating the Drug Delivery Devices Market.

Know More About Global Drug Delivery Devices Market Report?

Have a Query? Click Here

Other Related Reports

Pressure Infusor Comprehensive Study by Type (Manual Pressure Infusor, Automatic Pressure Infusor), Application (Infusion of IV Solutions, Infusion of Blood, Others), End-users (Hospitals, Clinics, L...
$ 3650
Transvaginal Endoscopy Comprehensive Study by Type (Flexible Endoscope, Rigid Endoscope), Application (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other...
$ 3500
Ultrasonic Scalpel Comprehensive Study by Type (Silicone Liner, Thermoplastic Elastomer (TPE), Polyurethane Liner), Application (Leg Disabled People, Arm Disabled People), Indication (Lung Biopsy, Gy...
$ 3650
Laboratory Freezers Comprehensive Study by Type (Enzyme Freezers, Laboratory Freezers, Explosion-proof Freezers, Flammable Material Freezers, Plasma Freezers, Ultra-low Temperature Freezers), Freezer...
$ 3750
Hearing Aid Batteries Comprehensive Study by Type (Primary battery, Secondary battery), Application (Household, Hospital), Industry Segmentation (Behind-the-ear (BTE) Hearing Aids, In-the-ear (ITE) H...
$ 3500
Breast Implants Comprehensive Study by Type (Saline solution, Silicone gel, Composite filler), Application (Cosmetic Surgery, Reconstructive Surgery), Category (Saline breast implants, Structured sal...
$ 3750